Galderma Group N
Financial ratios & Valuation

Historical Multiples (2021 – 2023)

2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-89.25-133.84-6.26KN/A-133.84
Price/Sales ratio
4.033.5087.08N/A3.50
Price/Book Value ratio
3.033.0466.76N/A3.04
Price/Cash Flow ratio
70.37118.442.16KN/A118.44
Price/Free Cash Flow ratio
203.42-273.518.12KN/A-273.51
Price/Earnings Growth ratio
N/A4.1564.03N/A4.15
Dividend Yield
N/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
69.74%68.24%70.07%N/A68.24%
Operating Profit Margin
9.63%9.10%13.01%N/A9.10%
Pretax Profit Margin
-2.33%-1.38%0.26%N/A-1.38%
Net Profit Margin
-4.51%-2.61%-1.38%N/A-2.61%
Effective Tax Rate
-5.64%-86.70%624.77%N/A-86.70%
Return on Assets
-1.23%-0.81%-0.45%N/A-0.81%
Return On Equity
-3.40%-2.27%-1.06%N/A-2.27%
Return on Capital Employed
3.08%3.38%4.91%N/A3.38%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/A
Quick Ratio
0.630.540.76N/A0.54
Cash ratio
0.150.110.23N/A0.11
Days of Sales Outstanding
77.8774.3456.00N/A74.34
Days of Inventory outstanding
122.01130.98124.35N/A130.98
Operating Cycle
199.88205.32180.35N/A205.32
Days of Payables Outstanding
176.91178.24165.09N/A178.24
Cash Conversion Cycle
22.9727.0715.26N/A27.07
Debt Ratios
Debt Ratio
0.440.440.38N/A0.44
Debt Equity Ratio
1.231.240.89N/A1.24
Long-term Debt to Capitalization
0.530.530.46N/A0.53
Total Debt to Capitalization
0.550.550.47N/A0.55
Interest Coverage Ratio
N/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
0.030.020.03N/A0.02
Company Equity Multiplier
2.762.772.32N/A2.77
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.050.020.04N/A0.02
Free Cash Flow / Operating Cash Flow Ratio
0.34-0.430.26N/A-0.43
Cash Flow Coverage Ratio
0.030.020.03N/A0.02
Short Term Coverage Ratio
0.470.294.25N/A0.29
Dividend Payout Ratio
N/AN/AN/AN/AN/A